Endonovo Therapeutics Inc. ENDV Archives - Page 2 of 5

WednesdayNov 06, 2019 9:26 am

QualityStocksNewsBreaks – Endonovo Therapeutics Inc.’s (ENDV) SofPulse(R) Reduces Opioid Prescriptions at New Hanover Regional Medical Center

Commercial-stage developer of innovative medical devices Endonovo Therapeutics (OTCQB: ENDV) was recently featured in a Wect.com article by Jack Bailey titled, ‘Medical device lowers opioid prescriptions at NHRMC’. The article highlights ENDV’s noninvasive Electroceutical(R) therapeutic device, SofPulse(R). According to the article, surgeons at New Hanover Regional Medical Center are utilizing SofPulse(R) as an alternative to narcotics to treat patients’ pain. SofPulse(R) works by using electromagnetic waves to lower inflammation and accelerate the recovery process. NHRMC urologist Dr. Roc McCarthy pointed out there has been a 30%-40% decline in post-op narcotic prescriptions since they began using the device six months ago.…

TuesdayNov 05, 2019 3:05 pm

QualityStocksNewsBreaks – Endonovo Therapeutics Inc. (ENDV) Names Strategic Advisor to CEO

Commercial-stage developer of innovative medical devices Endonovo Therapeutics (OTCQB: ENDV) recently named Dr. William Li, CEO and co-founder of the Angiogenesis Foundation, as a strategic advisor to the CEO. An article discussing the company reads, “The role of Li would be to strategically explore growth opportunities within the Endonovo target markets, the company said in a press release (http://ibn.fm/mCqAT). . . . ‘Dr. Li is a globally recognized medical professional and a business visionary with a strong track record of success,’ Endonovo Therapeutics CEO Alan Collier said in a news release. Just like the Endonovo team, Li sees the long-term potential…

FridayNov 01, 2019 9:45 am

QualityStocksNewsBreaks – Endonovo Therapeutics Inc. (ENDV) Announces Reverse Stock Split

Endonovo Therapeutics (OTCQB: ENDV), a commercial-stage developer of noninvasive Electroceutical(R) therapeutic devices, on Thursday announced its filing of a preliminary information statement with respect to a proposed reverse stock split of its common stock at a ratio of between 1 for 100 and 1-for-1,000. According to the update, the proposed reverse stock split effectiveness is contingent upon final SEC clearance of the Information Statement, mailing of the statement and a twenty-day waiting period, Endonovo’s sole director’s decision as to the final ratio of the reverse stock split, filing of a certificate of amendment to the company’s certificate of incorporation, and…

FridayOct 25, 2019 1:45 pm

QualityStocksNewsBreaks – Endonovo Therapeutics Inc.’s (ENDV) SofPulse® Receives Positive Review in Video Testimonial

Endonovo Therapeutics’ (OTCQB: ENDV) proprietary SofPulse(R) flagship device recently received a glowing review for minimizing pain from a foot-and-ankle specialist in Ohio who underwent tendon surgery. An article discussing the company reads, “In a homemade video, Dr. Jane Graenber, DPM, of the Foot and Ankle Wellness Center in Delaware, Ohio, attests that Endonovo’s SofPulse(R) electroceutical device has helped her to remain generally pain free a day after the tendon surgery, such that she says she has only used three doses of Tylenol for relief (no prescription pain pills) during the interim since her procedure (http://ibn.fm/H2n5X). . . . ‘This device…

MondayOct 21, 2019 10:10 am

Endonovo Therapeutics Inc. (ENDV) Appoints Strategic Advisor to the CEO to Explore Growth Opportunities

The new strategic advisor, Dr. William Li, is a globally recognized medical professional One of Li’s primary specialties is the identification of unmet medical market needs that can be addressed through technological advances Endonovo is working to develop solutions for major therapeutic needs, especially in regard to pain management Its Electroceutical® SofPulse® is clinically proven to provide post-operative pain relief and speed up recovery On September 30, 2019, Endonovo Therapeutics Inc. (OTCQB: ENDV), a commercial-stage developer of innovative medical devices, announced the appointment of Dr. William Li as a strategic advisor to the CEO. The role of Li would be…

FridayOct 18, 2019 3:11 pm

QualityStocksNewsBreaks – Endonovo Therapeutics Inc. (ENDV) Expanding Commercialization of Wearable Pain-Management Device

Endonovo Therapeutics (OTCQB: ENDV), a commercial-stage developer of noninvasive Electroceutical® therapeutic devices, has completed clinical trials and is currently expanding commercialization of its SofPulse® device that delivers pulsed electromagnetic frequencies for pain management. An article discussing the company reads, “In August, Endonovo announced its Q2 financial results, showing growth in both revenue and gross profits. However, since the economic potential for a safe, nonaddictive alternative to opioids is significant, the company’s continued progress as it reaches developmental and test milestones is clearly the key focus. Over the second quarter of 2019, the company expanded SofPulse® commercialization and announced the first…

FridayOct 18, 2019 11:01 am

Foot Specialist’s Testimonial About Surgery Highlights Non-Opioid Pain Therapy of Endonovo Therapeutics Inc. (ENDV) Device

Endonovo Therapeutics is developing a bioceutical device that provides an alternative to the prescription pain pills blamed for hundreds of thousands of deaths in recent years as part of a multinational opioid crisis Endonovo’s proprietary SofPulse® flagship device provides an electrical micro-current to the afflicted part of the body, particularly post-surgery, to minimize a patient’s need for pain relief medication A foot and ankle specialist in Ohio recently used the device following her own tendon surgery and provided a personal testimonial with a professional perspective of the device’s effectiveness in minimizing her pain The SofPulse® device is being evaluated professionally…

ThursdayOct 17, 2019 9:28 am

Endonovo Therapeutics Inc. (ENDV) Expanding Commercialization of SofPulse Pain Management Solution as Alternative to Opioids

As the U.S. attempts to address its opioid crisis, the need for safe and effective pain management solutions is growing Endonovo Therapeutics is making significant progress toward commercializing its SofPulse® device that delivers pulsed electromagnetic frequencies for pain management Endonovo has completed clinical trials and is currently expanding commercialization of the device Several strategic appointments have also been made recently to strengthen the Endonovo team and the company’s clinical work Endonovo Therapeutics Inc. (OTCQB: ENDV) is putting a lot of effort into the commercialization of SofPulse®, the company’s Electroceutical® wearable therapeutic device for pain management. The non-invasive, safe solution delivers…

MondaySep 30, 2019 10:51 am

QualityStocksNewsBreaks – Endonovo Therapeutics Inc. (ENDV) Appoints Recognized Medical Professional and Business Visionary Dr. William Li as Strategic Advisor to the CEO

Endonovo Therapeutics (OTCQB: ENDV), a commercial-stage developer of noninvasive Electroceutical® therapeutic devices, today announced its appointment of Dr. William Li as Strategic Advisor to the CEO. According to the update, Dr. Li and Endonovo CEO Alan Collier will work collaboratively and strategically to explore growth strategies for the company's contemplated market segments. "Dr. Li is a globally recognized medical professional and a business visionary with a strong track record of success,” Endonovo CEO Alan Collier said in the news release. “Like us, he takes a long-term view of medical advances and believes industry can play a pivotal role in shaping…

ThursdaySep 19, 2019 12:27 pm

QualityStocksNewsBreaks – Endonovo Therapeutics Inc. (ENDV) Receives Glowing Video Review on Revolutionary Medical Device

Endonovo Therapeutics (OTCQB: ENDV) develops, manufactures and distributes innovative medical devices focused on the rapid healing of wounds and reduction of pain, edema and inflammation on and in the human body. The company’s SofPulse® Electroceutical® Therapy device employs targeted microcurrents to transmit gentle pulses to the tissue to help ease swelling and accelerate the natural recovery process. The device was recently reviewed in a video by Dr. Jane Graenber of the Foot & Ankle Wellness Center following a tendon reconstruction surgery. In the video, Dr. Graenber discusses her experience with ENDV’s SofPulse®. “Here I am, late in the evening on…

Site Search

Company Search

Tag: Endonovo Therapeutics Inc. ENDV